Viridian Therapeutics, Inc. (VRDN) Earnings
NASDAQ·Healthcare·Biotechnology
$20.35
+5.39%
Mkt Cap $1.79B
EPS — Estimate vs Actual
Mkt Cap
$1.79B
P/E
—
Fwd P/E
—
P/S
25.23
Rev TTM
—
EPS TTM
-$3.48
NASDAQ·Healthcare·Biotechnology
$20.35
+5.39%
Mkt Cap $1.79B
Mkt Cap
$1.79B
P/E
—
Fwd P/E
—
P/S
25.23
Rev TTM
—
EPS TTM
-$3.48